Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma.
Li G, Wang D, Zhai Y, Pan C, Zhang J, Wang C, Huang R, Yu M, Li Y, Liu X, Liu Y, Wu F, Zhao Z, Hu H, Shi Z, Kahlert UD, Jiang T, Zhang W.
Li G, et al. Among authors: kahlert ud.
Cell Metab. 2024 Aug 6;36(8):1696-1710.e10. doi: 10.1016/j.cmet.2024.07.011.
Cell Metab. 2024.
PMID: 39111285
Free article.